The combined activation of GIPR and GLP-1R by tirzepatide not only improved both glucose-dependent insulin secretion and glucose tolerance in mice15, but also showed significantly better efficacy than semaglutide and dulaglutide with regard to glucose control and weight loss16,17. Here, GLP1R is linked to glucose measurement.